Competition Council approves take over of part of Astra Zeneca’s assets by Recordati

Georgiana Bendre 19/07/2017 | 17:06

The Competition Council approves the take over of a part of Astra Zeneca’s assets by Recordati in order to sell pharma products Betaloc and Betaloc ZOK in Romania.

„The objective of the economic concentration operation is represented by assets and exclusive rights on the sale of three pharma products for cardio-vascular diseases, Betaloc, Betaloc ZOK and Logimax in certain European countries and Israel. Competition council evaluated the economic concentration operator from the point of view of their compatibility with a normal competitive environment, respectively the possible non-competitive effects, according to the regulation on the economic concentrations. The analysis showed that the operation doesn’t bring obstacles on the national competition,” says the source.

Recordati S.p.A is a pharma company, active in research, factory and sale of pharma products and active pharma substances.

BR Magazine | Latest Issue

Download PDF or read online: November 2022 Issue | Business Review Magazine

The November 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Samsung Remains Top Consumer Tech Provider on Romanian Market.” Read
Georgiana Bendre | 29/11/2022 | 10:17

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu
    I agree with the storage and handling of my data by business-review.eu
    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue